Calendar Insmed Incorporated

Equities

INSM

US4576693075

Biotechnology & Medical Research

Market Closed - Nasdaq Other stock markets 01:30:00 12/07/2025 am IST			5-day change	1st Jan Change
98.18 ^USD	+1.57%		+0.39%	+42.21%

10/07	Insmed Insider Sold Shares Worth $5,537,460, According to a Recent SEC Filing	MT
07/07	RBC Lifts Price Target on Insmed to $108 From $106, Keeps Outperform Rating	MT

Chart calendar Insmed Incorporated

70b5f8a493b37.LBzGPqGeJdd7vjzqeOBPQs65LP_dUUNtnUnKe3vNtxA.X0iKX9npFYY-8U6PHZQoAK_WRJS_AxUkxDu9KQmS2FdFVpITxutUuxrbcQ~0c3292b670cf59b09d4455ad493c5107

Upcoming events on Insmed Incorporated

31/07/2025	Q2 2025 Earnings Release (Projected)
23/10/2025	Q3 2025 Earnings Release (Projected)
19/02/2026	Q4 2025 Earnings Release (Projected)
30/04/2026	Q1 2026 Earnings Release (Projected)

Past events on Insmed Incorporated

11/06/2025 06:50 pm	Goldman Sachs Global Healthcare Conference
10/06/2025 05:30 pm	TPIP Phase 2b PAH Topline Results Call
21/05/2025 09:09 pm	American Thoracic Society International Conference
21/05/2025 02:45 am	American Thoracic Society International Conference
21/05/2025 12:00 am	American Thoracic Society International Conference
20/05/2025 09:45 pm	American Thoracic Society International Conference
20/05/2025 12:00 am	American Thoracic Society International Conference
19/05/2025 10:33 pm	American Thoracic Society International Conference
19/05/2025 12:00 am	American Thoracic Society International Conference
15/05/2025 06:30 pm	Annual General Meeting
14/05/2025 02:50 am	Bank of America Global Healthcare Conference
08/05/2025 05:30 pm	Q1 2025 Earnings Call
08/05/2025 04:30 pm	Q1 2025 Earnings Release
11/03/2025 05:30 pm	Leerink Partners Global Healthcare Conference
03/03/2025 07:40 pm	TD Cowen Healthcare Conference
20/02/2025 06:30 pm	Q4 2024 Earnings Call
20/02/2025 05:30 pm	Q4 2024 Earnings Release
14/01/2025 04:30 am	JP Morgan Healthcare Conference
11/12/2024 04:00 pm	Nasdaq Investor Conference
04/12/2024 09:45 pm	Evercore ISI HealthCONx Conference

Annual results

Fiscal Period	December	2022	2023	2024	2025	2026	2027
Net sales Million USD	Released Forecast Spread	245 248 -0.9%	305 303 0.64%	364 362 0.47%	464	993	1 878
EBITDA Million USD	Released Forecast Spread	-447 -441 -1.38%	-699 -687 -1.81%	-867 -834 -3.93%	-944	-676	-114
EBIT Million USD	Released Forecast Spread	-457 -442 -3.4%	-710 -685 -3.53%	-878 -850 -3.32%	-956	-676	-119
Earnings before Tax (EBT) Million USD	Released Forecast Spread	-480 -460 -4.3%	-747 -725 -2.97%	-910 -886 -2.73%	-1 006	-721	-172
Net income Million USD	Released Forecast Spread	-482 -462 -4.24%	-750 -726 -3.28%	-914 -887 -3.08%	-1 005	-729	-174
EPS USD	Released Forecast Spread	-3,91 -3,73 -4.78%	-5,34 -5,21 -2.54%	-5,57 -5,38 -3.53%	-5,34	-3,63	-0,85
Announcement Date		23/02/23	22/02/24	20/02/25	-

Quarterly results

Fiscal Period	March	2023 Q3	2023 Q4	2024 Q1	2024 Q2	2024 Q3	2024 Q4	2025 Q1	2025 Q2	2025 Q3	2025 Q4	2026 Q1	2026 Q2	2026 Q3	2026 Q4
Net sales Million USD	Released Forecast Spread	79,1 79,3 -0.32%	83,7 82,6 1.31%	75,5 78,8 -4.14%	90,3 87,8 2.91%	93,4 93,2 0.21%	104 102 1.95%	92,8 91,2 1.73%	104	114	152	170	208	252	307
EBITDA Million USD	Released Forecast Spread	-145 -125 -15.94%	-176 -157 -12.06%		-286 -169 -68.91%	-211 -178 -18.54%	-228 -192 -18.37%	-245 -236 -3.81%	-233	-237	-194
EBIT Million USD	Released Forecast Spread	-148 -145 -1.75%	-178 -155 -14.77%	-146 -172 15.53%	-289 -175 -65.23%	-213 -189 -12.65%	-230 -204 -13.14%	-248 -231 -7.34%	-239	-256	-239	-218	-183	-174	-155
Earnings before Tax (EBT) Million USD	Released Forecast Spread	-158 -156 -1.79%	-185 -164 -12.97%	-157 -183 14.64%	-300 -191 -56.97%	-220 -200 -9.82%	-234 -213 -9.91%	-256 -235 -8.59%	-246	-259	-246	-212	-203	-178	-154
Net income Million USD	Released Forecast Spread	-159 -155 -2.63%	-186 -163 -14.48%	-157 -181 13%	-301 -187 -61.01%	-221 -199 -10.86%	-236 -211 -11.9%	-257 -240 -7.04%	-246	-258	-245	-212	-203	-178	-154
EPS USD	Released Forecast Spread	-1,11 -1,13 1.97%	-1,28 -1,15 -11.71%	-1,06 -1,24 14.57%	-1,94 -1,19 -62.36%	-1,27 -1,21 -4.89%	-1,32 -1,17 -12.35%	-1,42 -1,34 -6.22%	-1,32	-1,35	-1,27	-1,16	-1,07	-0,92	-0,79
Announcement Date		26/10/23	22/02/24	09/05/24	08/08/24	31/10/24	20/02/25	08/05/25	-	-	-	-	-	-	-

Upcoming sector events for Insmed Incorporated

23/07/2025	VIKING THERAPEUTICS, INC.: Q2 2025 Earnings Release (Projected)
29/07/2025	WUXI APPTEC CO., LTD.: Q2 2025 Earnings Release
30/07/2025	CASSAVA SCIENCES, INC.: Q2 2025 Earnings Release (Projected)
30/07/2025	XENCOR, INC.: Q2 2025 Earnings Release (Projected)
31/07/2025	DYNE THERAPEUTICS, INC.: Q2 2025 Earnings Release (Projected)
31/07/2025	KURA ONCOLOGY, INC.: Q2 2025 Earnings Release (Projected)
31/07/2025	SANA BIOTECHNOLOGY, INC.: Q2 2025 Earnings Release (Projected)
31/07/2025	KEROS THERAPEUTICS, INC.: Q2 2025 Earnings Release (Projected)
31/07/2025	INSMED INCORPORATED: Q2 2025 Earnings Release (Projected)
31/07/2025	SPYRE THERAPEUTICS, INC.: Q2 2025 Earnings Release (Projected)

More events

Past sector events for Insmed Incorporated

10/07/2025 04:30 pm	KALVISTA PHARMACEUTICALS, INC.: Q4 2025 Earnings Release
10/07/2025 01:31 am	NURIX THERAPEUTICS, INC.: Q2 2025 Earnings Release
05/07/2025 07:54 am	PHARMAESSENTIA CORPORATION: June 2025 Sales and Revenue Release
13/06/2025	SANBIO COMPANY LIMITED: Q1 2025 Earnings Release
09/06/2025 12:16 pm	LUMOSA THERAPEUTICS CO., LTD.: May 2025 Sales and Revenue Release
05/06/2025 01:51 pm	PHARMAESSENTIA CORPORATION: May 2025 Sales and Revenue Release
05/06/2025 01:16 pm	TAIMED BIOLOGICS INC.: May 2025 Sales and Revenue Release
15/05/2025 05:30 pm	TAYSHA GENE THERAPIES, INC.: Q1 2025 Earnings Release
15/05/2025	LIGACHEM BIOSCIENCES INC.: Q1 2025 Earnings Release
15/05/2025	PEPTRON, INC.: Q1 2025 Earnings Release